Alternative Lengthening of Telomeres (ALT) Predicts Disease Free Survival in Small Well Differentiated Pancreatic Neuroendocrine Tumors

被引：0
|
作者：
Memon, Raima [1 ]
Pisipati, Sailaja [2 ]
Al Diffalha, Sameer [3 ]
Hartley, Christopher [2 ]
Rose, J. Bart [3 ]
Reid, Michelle [4 ]
Gleeson, Ferga [2 ]
Graham, Rondell [2 ]
机构：
[1] Emory Univ, Birmingham, AL USA
[2] Mayo Clin, Rochester, MN USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1477
引用
收藏
页码：S1846 / S1847
页数：2
相关论文
共 50 条
  • [1] Alternative Lengthening of Telomeres Predicts Metastatic Disease and Poor Survival in Patients With Pancreatic Neuroendocrine Tumors
    Kinowaki, Y.
    Matsuda, Y.
    Fukumura, Y.
    Kudo, A.
    Akashi, T.
    Kitagawa, M.
    PANCREAS, 2019, 48 (10) : 1462 - 1462
  • [2] Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
    Singhi, Aatur D.
    Liu, Ta-Chiang
    Roncaioli, Justin L.
    Cao, Dengfeng
    Zeh, Herbert J.
    Zureikat, Amer H.
    Tsung, Allan
    Marsh, J. Wallis
    Lee, Kenneth K.
    Hogg, Melissa E.
    Bahary, Nathan
    Brand, Randall E.
    McGrath, Kevin M.
    Slivka, Adam
    Cressman, Kristi L.
    Fuhrer, Kimberly
    O'Sullivan, Roderick J.
    CLINICAL CANCER RESEARCH, 2017, 23 (02) : 600 - 609
  • [3] Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients With Pancreatic Neuroendocrine Tumors
    Singhi, A. D.
    Liu, T. -C.
    Roncaioli, J. L.
    Zeh, H. J.
    Zureikat, A. H.
    Tsung, A.
    Marsh, J. W.
    Lee, K. K.
    Hogg, M. E.
    Bahary, N.
    Brand, R. E.
    McGrath, K.
    Slivka, A.
    Cressman, K. L.
    Fuhrer, K.
    O'Sullivan, R. J.
    PANCREAS, 2016, 45 (10) : 1539 - 1539
  • [4] Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
    Claudio Luchini
    Rita T. Lawlor
    Samantha Bersani
    Caterina Vicentini
    Gaetano Paolino
    Paola Mattiolo
    Antonio Pea
    Sara Cingarlini
    Michele Milella
    Aldo Scarpa
    Current Oncology Reports, 2021, 23
  • [5] Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
    Luchini, Claudio
    Lawlor, Rita T.
    Bersani, Samantha
    Vicentini, Caterina
    Paolino, Gaetano
    Mattiolo, Paola
    Pea, Antonio
    Cingarlini, Sara
    Milella, Michele
    Scarpa, Aldo
    CURRENT ONCOLOGY REPORTS, 2021, 23 (09)
  • [6] Predicting recurrence in pancreatic neuroendocrine tumours: role of ARX and alternative lengthening of telomeres (ALT)
    Neyaz, Azfar
    Crotty, Rory
    Rickelt, Steffen
    Pankaj, Amaya
    Stojanova, Marija
    Michelakos, Theodoros P.
    Sekigami, Yurie
    Kontos, Filippos
    Parrack, Paige H.
    Patil, Deepa T.
    Heaphy, Christopher M.
    Ferrone, Cristina R.
    Deshpande, Vikram
    HISTOPATHOLOGY, 2023, 83 (04) : 546 - 558
  • [7] Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival
    Kim, Joo Young
    Brosnan-Cashman, Jacqueline A.
    An, Soyeon
    Kim, Sung Joo
    Song, Ki-Byung
    Kim, Min-Sun
    Kim, Mi-Ju
    Hwang, Dae Wook
    Meeker, Alan K.
    Yu, Eunsil
    Kim, Song Cheol
    Hruban, Ralph H.
    Heaphy, Christopher M.
    Hong, Seung-Mo
    CLINICAL CANCER RESEARCH, 2017, 23 (06) : 1598 - 1606
  • [8] The Diagnostic and Prognostic Utility of Incorporating DAXX, ATRX, and Alternative Lengthening of Telomeres (ALT) to the Evaluation of Pancreatic Neuroendocrine Tumors (PanNETs)
    Heaphy, Christopher M.
    Singhi, Aatur D.
    HUMAN PATHOLOGY, 2023, 132 : 1 - 11
  • [9] CT Radiogenomic Characterization of the Alternative Lengthening of Telomeres Phenotype in Pancreatic Neuroendocrine Tumors
    McGovern, Jonathan M.
    Singhi, Aatur D.
    Borhani, Amir A.
    Furlan, Alessandro
    McGrath, Kevin M.
    Zeh, Herbert J., III
    Bahary, Nathan
    Dasyam, Anil K.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 211 (05) : 1020 - 1025
  • [10] Activation of Alternative Lengthening of Telomeres (ALT) in Primary Pancreatic Neuroendocrine Tumors Serves as Both a Prognostic Biomarker and Potential Therapeutic Target
    Rizzo, Anthony
    Brosnan-Cashman, Jacqueline
    Graham, Mindy
    Hruban, Ralph
    Heaphy, Christopher
    PANCREAS, 2018, 47 (03) : 353 - 353
12345